Sign in

CIK 0001850902

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Alpha Teknova, Inc.

Sign in to watch
Ticker
TKNO
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943368109
Phone
+1 831-637-1100
Business address
2451 BERT DRIVE, HOLLISTER, CA, 95023
  1. 4 Open-market sale Chief People Officer sold 3,119 shares at $2.04 ($6,351)
  2. 4 Open-market buy President and CEO bought 4,665 shares at $1.67 ($7,772)
  3. 4 Open-market buy Chief Commercial Officer bought 3,915 shares at $1.67 ($6,522)
  4. 4 Open-market buy Chief People Officer bought 3,119 shares at $1.67 ($5,196)
  5. 4 Grant or award General Counsel and CCO acquired 14,000 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 14,000 shares (grant or award)
  7. 4 Grant or award Chief People Officer acquired 14,000 shares (grant or award)
  8. 4 Grant or award President and CEO acquired 43,125 shares (grant or award)
  9. 4 Grant or award Chief Commercial Officer acquired 14,000 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief People Officer bought 2,818 shares at an average $6.07 ($17,099)
  13. 4 Open-market buy President and CEO bought 3,008 shares at an average $7.11 ($21,387)
  14. 4 Open-market buy Chief Commercial Officer bought 1,422 shares at $4.23 ($6,019)
  15. 4 Exercise or conversion President and CEO acquired 40,000 shares (option exercise)
  16. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.61 ($46,096)
  17. 4 Open-market buy Director bought 10,000 shares at an average $4.98 ($49,750)
  18. 4 Open-market buy President and CEO bought 18,000 shares at $5.13 ($92,338)
  19. 4 Grant or award Director acquired 9,357 shares (grant or award)
  20. 4 Grant or award Director acquired 9,357 shares (grant or award)

Page 3 of 5 · 93 filings